Expansion Opportunity Sepax Technologies is planning a major geographic expansion to Glasgow, United Kingdom, with a $100 million U.S. headquarters project and move from Delaware by the end of 2026. This signals a ramp in regional operations, increased demand for chromatography consumables, media, and related services in Europe, presenting cross-border sales opportunities for high-performance HPLC columns, process media, and support.

Purification Focus The company specializes in high-resolution chromatography for biologics across diverse modalities including mAbs, bispecific antibodies, ADCs, AAVs, VLPs, and nucleic acids. This breadth indicates ongoing needs for robust analytics, upstream/downstream purification media, and scalable column solutions that can be positioned to biotech firms and contract manufacturers expanding biologics pipelines.

Growth Momentum Historical headcount growth and a stated plan to hire dozens of employees by end of 2023, along with a revenue range of 25 to 50 million and a substantial funding pool, suggest aggressive product development, capacity expansion, and potential demand for new process media lots, service support, and technology licensing opportunities.

Strategic Partnerships Past collaborations with external science partners and a track record in supplying LC consumables and bulk media create opportunities to propose expanded collaboration, co-development projects, or preferred supplier arrangements with R&D teams and CRO/CMO partners looking to optimize purification workflows.

Digital & Compliance Readiness Active digital footprints and tech stack signals (LinkedIn Ads, Google Search Console, content across industry portals) indicate readiness for targeted outreach, inbound marketing alignment, and efficient lead capture. Emphasize data-driven campaigns, regional language and regulatory considerations for Europe, and demonstration of reproducibility and real-world performance to win procurement discussions.